NCT00603044View on ClinicalTrials.gov

Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome

PHASE4CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

August 31, 2009

Conditions

Childhood Obstructive Sleep Apnea Syndrome (OSAS)

Interventions

DRUG

fluticasone furoate

treatment with fluticasone furoate (55 mcg/nostril once daily) for 2 weeks prior to adenotonsillectomy

Trial Locations (1)

60637

University of Chicago, Chicago

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Chicago

OTHER